Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 373 entries
View as:

A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA

Phase: N/A Priority: Normal
NCT ID: NCT00693186 Org: User:
Start: 10/31/08 End: 03/31/10 Due: 03/31/11

Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT05144945 Org: User:
Start: 12/07/21 End: 09/01/22 Due: 09/01/23

Regulatory Post-Marketing Surveillance Study for TETRAXIM™

Phase: N/A Priority: Normal
NCT ID: NCT01437423 Org: User:
Start: 06/30/11 End: 11/30/15 Due: 11/30/16

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04024228 Org: User:
Start: 10/28/19 End: 06/05/20 Due: 06/05/21

DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants

Phase: N/A Priority: Normal
NCT ID: NCT02817451 Org: User:
Start: 07/14/16 End: 02/22/19 Due: 02/22/20

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT00993447 Org: User:
Start: 10/31/09 End: 03/31/12 Due: 03/31/13

Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT04544267 Org: User:
Start: 09/15/20 End: 07/31/26 Due: 07/31/27

Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults

Phase: N/A Priority: Normal
NCT ID: NCT01032980 Org: User:
Start: 12/31/09 End: 07/31/11 Due: 07/31/12

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22

Phase: N/A Priority: Normal
NCT ID: NCT05078060 Org: User:
Start: 10/12/21 End: 12/02/21 Due: 12/02/22

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months

Phase: N/A Priority: Normal
NCT ID: NCT00956046 Org: User:
Start: 09/30/09 End: 06/30/11 Due: 06/30/12

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®

Phase: N/A Priority: Normal
NCT ID: NCT02979535 Org: User:
Start: 11/16/16 End: 03/25/19 Due: 03/25/20

Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01411241 Org: User:
Start: 07/18/11 End: 04/30/14 Due: 04/30/15

Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01519713 Org: User:
Start: 01/31/12 End: 12/31/12 Due: 12/31/13

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT03673462 Org: User:
Start: 09/17/18 End: 03/16/23 Due: 03/16/24

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

Phase: N/A Priority: Normal
NCT ID: NCT00855855 Org: User:
Start: 02/28/09 End: 12/31/14 Due: 12/31/15

Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update

Phase: N/A Priority: Normal
NCT ID: NCT04170140 Org: User:
Start: 01/07/20 End: 03/05/20 Due: 03/05/21

Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00777790 Org: User:
Start: 02/29/04 End: 04/30/05 Due: 04/30/06

Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01475539 Org: User:
Start: 11/30/11 End: 11/30/13 Due: 11/30/14

Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India

Phase: N/A Priority: Normal
NCT ID: NCT01053143 Org: User:
Start: 01/31/10 End: 09/30/10 Due: 09/30/11

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT01374516 Org: User:
Start: 06/08/11 End: 03/05/18 Due: 03/05/19

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02222870 Org: User:
Start: 08/31/14 End: 06/30/15 Due: 06/30/16

Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose

Phase: N/A Priority: Normal
NCT ID: NCT01439165 Org: User:
Start: 11/30/11 End: 02/28/17 Due: 02/28/18

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland

Phase: N/A Priority: Normal
NCT ID: NCT04478084 Org: User:
Start: 08/04/20 End: 07/21/22 Due: 07/21/23

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT00483574 Org: User:
Start: 05/31/07 End: 04/30/09 Due: 04/30/10

Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation

Phase: N/A Priority: Normal
NCT ID: NCT00718146 Org: User:
Start: 06/30/08 End: 09/30/08 Due: 09/30/09